ROYAL BANK OF CANADA - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$1,000
-50.0%
1,085
-8.2%
0.00%
Q2 2023$2,0000.0%1,182
+18.2%
0.00%
Q1 2023$2,000
+100.0%
1,0000.0%0.00%
Q4 2022$1,0000.0%1,000
+100.0%
0.00%
Q3 2022$1,0000.0%5000.0%0.00%
Q2 2022$1,0000.0%5000.0%0.00%
Q1 2022$1,000
-50.0%
5000.0%0.00%
Q4 2021$2,000
-60.0%
500
-64.3%
0.00%
Q3 2021$5,000
-68.8%
1,400
-72.1%
0.00%
Q2 2021$16,000
+23.1%
5,009
+34.9%
0.00%
Q1 2021$13,000
+18.2%
3,714
-20.2%
0.00%
Q4 2020$11,000
+1000.0%
4,653
+808.8%
0.00%
Q3 2020$1,0000.0%512
+2.4%
0.00%
Q2 2020$1,000
-66.7%
500
-55.9%
0.00%
Q1 2020$3,000
-72.7%
1,134
-72.8%
0.00%
Q4 2019$11,000
+120.0%
4,170
+238.2%
0.00%
Q3 2019$5,000
-44.4%
1,233
-53.2%
0.00%
Q2 2019$9,000
+350.0%
2,634
+249.8%
0.00%
Q1 2019$2,0000.0%753
-26.9%
0.00%
Q4 2018$2,000
-60.0%
1,030
-20.0%
0.00%
Q3 2018$5,000
+400.0%
1,288
+421.5%
0.00%
Q2 2018$1,000247
+190.6%
0.00%
Q1 2018$0
-100.0%
85
-5.6%
0.00%
Q4 2017$1,000
-97.1%
90
-97.3%
0.00%
Q3 2017$35,000
+337.5%
3,304
+226.8%
0.00%
Q1 2017$8,000
-57.9%
1,011
-62.1%
0.00%
Q4 2016$19,000
+26.7%
2,666
-11.1%
0.00%
Q3 2016$15,0003,000
+29900.0%
0.00%
Q1 2016$010
+233.3%
0.00%
Q3 2015$030.0%0.00%
Q2 2015$0
-100.0%
3
-99.0%
0.00%
Q2 2013$1,0003000.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders